Studies on the Antileishmanial Mechanism of Action of the Arylimidamide DB766: Azole Interactions and Role of CYP5122A1 (vol 58, pg 4682, 2014)

导出原文传递

翻译打印收藏纠错

作者： Pandharkar, Trupti ^[1] ; Zhu, Xiaohua ^[2] ; Mathur, Radhika ^[3] ; Jiang, Jinmai ; Schmittgen, Thomas D. ; Shaha, Chandrima ; Werbovetz, Karl A.

作者单位： Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 ^[1] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500 W 12Th Ave, Columbus, OH 43210 USA ^[2] Natl Inst Immunol, Cell Death & Differentiat Res Lab, New Delhi 110067, India ^[3]

发布时间 2018-07-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Antimicrobial agents and chemotherapy.

2018年62卷1期

e01124-17页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Studies on the Antileishmanial Mechanism of Action of the Arylimidamide DB766: Azole Interactions and Role of CYP5122A1 (vol 58, pg 4682, 2014)

Antimicrobial agents and chemotherapy.

相似文献

Antimicrobial agents and chemotherapy.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Studies on the Antileishmanial Mechanism of Action of the Arylimidamide DB766: Azole Interactions and Role of CYP5122A1 (vol 58, pg 4682, 2014)

Antimicrobial agents and chemotherapy.

相似文献

Antimicrobial agents and chemotherapy.

相关期刊

检索历史清除